![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ando T. Goto Y. Ishiguro K. Maeda O. Watanabe O. Ohmiya N. Niwa Y. Hamajima N. El-Omar E. Goto H.
Publisher: Springer Publishing Company
ISSN: 1568-5608
Source: Inflammopharmacology, Vol.15, Iss.1, 2007-02, pp. : 10-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clarithromycin for Helicobacter pylori infection
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Strategy for the Treatment of Helicobacter pylori Infection
Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Updated guidelines for Helicobacter pylori infection
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of Helicobacter pylori Infection in Children
Current Pharmaceutical Design, Vol. 6, Iss. 15, 2000-10 ,pp. :